Safety, stability and immunogenicity of an oral DNA vaccine against Newcastle disease.
- Author:
Xue-Ya LIANG
1
;
Wei-Huan FANG
;
Ling-Li JIANG
Author Information
1. Institute of Preventive Veterinary Medicine, Zhejiang University, Hangzhou 310029, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Chickens;
Immunity, Cellular;
immunology;
Immunity, Humoral;
immunology;
Mice;
Newcastle Disease;
immunology;
virology;
Plasmids;
Polymerase Chain Reaction;
Salmonella typhimurium;
genetics;
metabolism;
Vaccines, DNA;
adverse effects;
genetics;
immunology
- From:
Chinese Journal of Biotechnology
2003;19(1):24-29
- CountryChina
- Language:Chinese
-
Abstract:
Mice and 3-day-old chickens were orally inoculated with the recombinant attenuated Salmonella typhimurium strain ZJ111 carrying pcDNA3-F expression plasmid encoding the fusion protein of Newcastle disease virus (NDV). The results showed that ZJ111/pcDNA3-F was relatively safe. The recombinant plasmid pcDNA3-F was stable within the host stain ZJ111 in vitro and in vivo as shown by restriction enzyme analysis and PCR identification of the F gene. In an experimental vaccination study, 3-day-old chickens were orally immunized with ZJ111/pcDNA3-F with a dose of 108 cfu per chicken and boosted two weeks later. At week 4 post boosting, all chickens were challenged with a lethal dose of a virulent NDV strain F48 E9. The results showed that oral vaccination with ZJ111/pcDNA3-F induced stronger humoral and cellular immune responses than intramuscular immunization with naked pcDNA3-F plasmid. It also exhibited higher protection rate than the latter (66.7% vs 50%). This study indicates that the DNA vaccine using attenuated Salmonella typhimurium as delivery carrier had good safety, stability and immunogenicity and exhibited good potential of low cost and convenience for poultry disease control.
